ReducING tardive dyskinesia (TD) with INGREZZA® (valbenazine)
SUBSTANTIAL IMPROVEMENT
AND WORKS QUICKLY
>10X TD Reduction at 6 WEEKS vs placebo*
Response was seen by most as early as 2 WEEKS†
Achieving Remission
No or minimal movements at 48 WEEKS in 59% of people‡
Actor portrayal
*In a 6-week clinical trial, based on average change from baseline to Week 6 on the Abnormal Involuntary Movement Scale (AIMS). Results for INGREZZA 80 mg –3.2 (n=79) vs placebo –0.1 (n=76).
†Individual results may vary. At Week 2, 52% (41/79) of people taking INGREZZA 80 mg had a 2-point or greater reduction on AIMS in the 6-week clinical trial.
‡In a post-clinical study evaluation of a 48-week trial, 59% (61/103) of people who completed the trial taking INGREZZA (40 mg and 80 mg) achieved a score of 1 or less for each body part measured with AIMS at Week 48. The results are descriptive in nature.
Actor portrayals
Actor portrayals
MakING remission the goal for TD
9 in 10 PEOPLE WITH TD
agree that achieving no or minimal movements (remission) is the goal of TD treatment§
§In a survey of 150 US adults diagnosed with TD. Conducted by The Harris Poll on behalf of Neurocrine Biosciences between December 12–31, 2024. The survey asked: "To what extent do you agree or disagree with the following statement, 'The ultimate goal for your TD treatment is to achieve no or minimal uncontrolled movements.'"
Want to learn more about the benefits of INGREZZA?
Sign up for infoBeING the #1 prescribed TD treatment isn't the only accomplishment we're proud of
- 20 clinical studies with 576 people with TD who took INGREZZA
- 8 years of real-world experience
- 3 simple and effective dosing options
- Starts at an effective dose
Common side effects of INGREZZA in people with tardive dyskinesia
The most common side effects of INGREZZA or INGREZZA SPRINKLE in people with tardive dyskinesia are sleepiness and tiredness.
What should I do if I experience side effects?
These are not all of the possible side effects of INGREZZA or INGREZZA SPRINKLE. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch at www.fda.gov/medwatch or call 1-800-FDA-1088.
INGREZZA is unlike other TD treatments
Watch Carnie Wilson uncover inspirING stories from the TD community
You’re not alone in talking about tardive dyskinesia (TD)
Thousands of people have already taken the first step toward talking with their healthcare provider about TD. Within the last year,†‖*‡ the Doctor Discussion Guide has been downloaded over 4000 times, helping people feel more prepared and supported during this important conversation.
†‖*‡Source: Google Analytics 4. January 1, 2025–August 31, 2025.